Impact of Lymph Node Ratio in Patients with Stage IIIC Endometrial Carcinoma Treated with Postoperative Radiotherapy

References

• Siegel RL , MillerKD, JemalA. Cancer statistics, 2019. CA Cancer J. Clin.69(1), 7–34 (2019).
   PubMed Web of Science ®Google Scholar
• Creutzberg CL , van PuttenWL, KoperPCet al. Surgery and postoperative radiotherapy versus surgery alone for patients with stage-1 endometrial carcinoma: multicentre randomised trial. PORTEC Study Group. Post Operative Radiation Therapy in Endometrial Carcinoma. Lancet355(9213), 1404–1411 (2000).
   PubMed Web of Science ®Google Scholar
• Papanikolaou A , KalogiannidisI, GoutzioulisMet al. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer. Arch. Gynecol. Obstet.274(2), 91–96 (2006).
   PubMedGoogle Scholar
• Lewin SN , HerzogTJ, BarrenaMedel NIet al. Comparative performance of the 2009 International Federation of Gynecology and Obstetrics’ staging system for uterine corpus cancer. Obstet. Gynecol.116(5), 1141–1149 (2010).
   PubMed Web of Science ®Google Scholar
• Onal C , SariSY, YildirimBAet al. A multi-institutional analysis of sequential versus ‘sandwich’ adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma. J. Gynecol. Oncol.30(3), e28 (2019).
   PubMed Web of Science ®Google Scholar
• Onal C , YildirimBA, SariSYet al. Treatment outcomes of endometrial cancer patients with paraaortic lymph node metastasis: a multi-institutional analysis. Int. J. Gynecol. Cancer29(1), 94–101 (2019).
   PubMed Web of Science ®Google Scholar
• Shaikh T , ChurillaTM, Mantia-SmaldoneGM, ChuC, RubinSC, AndersonPR. The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma. Gynecol. Oncol.141(3), 434–439 (2016).
   PubMed Web of Science ®Google Scholar
• Secord AA , HavrileskyLJ, O’MalleyDMet al. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer. Gynecol. Oncol.114(3), 442–447 (2009).
   PubMed Web of Science ®Google Scholar
• Yuan Y , YouJ, LiX, WangW. Adjuvant chemotherapy after radiotherapy or concurrent chemoradiotherapy for pelvic lymph node-positive patients with locally advanced cervical cancer: a propensity score matching analysis. Int. J. Gynecol. Cancerdoi:10.1136/ijgc-2020-001230 (2020) ( Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• He C , SunS, ZhangY, LinX, LiS. Score for the overall survival probability of patients with pancreatic adenocarcinoma of the body and tail after surgery: a novel nomogram-based risk assessment. Front. Oncol.10, 590 (2020).
   PubMed Web of Science ®Google Scholar
• Karjol U , JonnadaP, ChandranathA, CherukuruS. Lymph node ratio as a prognostic marker in rectal cancer survival: a systematic review and meta-analysis. Cureus12(5), e8047 (2020).
   PubMed Web of Science ®Google Scholar
• Fleming ND , SolimanPT, WestinSNet al. Impact of lymph node ratio and adjuvant therapy in node-positive endometrioid endometrial cancer. Int. J. Gynecol. Cancer25(8), 1437–1444 (2015).
   PubMed Web of Science ®Google Scholar
• Polterauer S , KhalilS, ZivanovicOet al. Prognostic value of lymph node ratio and clinicopathologic parameters in patients diagnosed with stage IIIC endometrial cancer. Obstet. Gynecol.119(6), 1210–1218 (2012).
   PubMed Web of Science ®Google Scholar
• Ayhan A , TopfedaisiOzkan N, OzMet al. Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study. J. Gynecol. Oncol.29(4), e48 (2018).
   PubMed Web of Science ®Google Scholar
• Chan JK , KappDS, CheungMKet al. The impact of the absolute number and ratio of positive lymph nodes on survival of endometrioid uterine cancer patients. Br. J. Cancer97(5), 605–611 (2007).
   PubMed Web of Science ®Google Scholar
• Benedetti Panici P , BasileS, ManeschiFet al. Systematic pelvic lymphadenectomy vs. no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J. Natl Cancer Inst.100(23), 1707–1716 (2008).
   PubMedGoogle Scholar
• Group AES , BlakeP, SwartAMet al.Adjuvant external beam radiotherapy in the treatment of endometrial cancer (MRC ASTEC and NCIC CTG EN.5 randomised trials): pooled trial results, systematic review, and meta-analysis. Lancet373(9658), 137–146 (2009).
   PubMed Web of Science ®Google Scholar
• Chan JK , UrbanR, CheungMKet al. Lymphadenectomy in endometrioid uterine cancer staging: how many lymph nodes are enough? A study of 11,443 patients. Cancer109(12), 2454–2460 (2007).
   PubMed Web of Science ®Google Scholar
• Todo Y , KatoH, KaneuchiM, WatariH, TakedaM, SakuragiN. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet375(9721), 1165–1172 (2010).
   PubMed Web of Science ®Google Scholar
• Havrilesky LJ , CragunJM, CalingaertBet al. Resection of lymph node metastases influences survival in stage IIIC endometrial cancer. Gynecol. Oncol.99(3), 689–695 (2005).
   PubMed Web of Science ®Google Scholar
• Abu-Rustum NR , IasonosA, ZhouQet al. Is there a therapeutic impact to regional lymphadenectomy in the surgical treatment of endometrial carcinoma? Am. J. Obstet. Gynecol. 198(4), 457e451–455 discussion 457; e455–456 (2008).
   Web of Science ®Google Scholar
• Aalders JG , ThomasG. Endometrial cancer – revisiting the importance of pelvic and para aortic lymph nodes. Gynecol. Oncol.104(1), 222–231 (2007).
   PubMed Web of Science ®Google Scholar
• Cragun JM , HavrileskyLJ, CalingaertBet al. Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer. J. Clin. Oncol.23(16), 3668–3675 (2005).
   PubMed Web of Science ®Google Scholar
• Altin D , TaskinS, KahramanogluIet al. Combination of sentinel lymph node mapping and uterine frozen section examination to reduce side-specific lymphadenectomy rate in endometrial cancer: a Turkish Gynecologic Oncology Group study (TRSGO-SLN-002). Int. J. Gynecol. Cancer30(7), 1005–1011 (2020).
   PubMed Web of Science ®Google Scholar
• Grassi T , MarianiA, CibulaDet al. A prospective multicenter international single-arm observational study on the oncological safety of the sentinel lymph node algorithm in stage I intermediate-risk endometrial cancer (SELECT, SEntinel Lymph node Endometrial Cancer Trial). Int. J. Gynecol. Cancer30(10), 1627–1632 (2020).
   PubMed Web of Science ®Google Scholar
• Aarts JWM , BurgLC, KasiusJCet al. Patients’ and gynecologists’ views on sentinel lymph node mapping in low- and intermediate-risk endometrial cancer: a Dutch vignette study. Int. J. Gynecol. Cancer30(6), 813–818 (2020).
   PubMed Web of Science ®Google Scholar
• Bristow RE , ZahurakML, AlexanderCJ, ZellarsRC, MontzFJ. FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival. Int. J. Gynecol. Cancer13(5), 664–672 (2003).
   PubMed Web of Science ®Google Scholar
• Gadducci A , GuerrieriME, CosioSet al. Rates, sites and times of recurrence and clinical outcome of endometrial cancer patients with histologically positive nodes: an Italian two-center retrospective study. Anticancer Res.38(3), 1695–1703 (2018).
   PubMed Web of Science ®Google Scholar
• Boothe D , OrtonA, OdeiBet al. Chemoradiation versus chemotherapy or radiation alone in stage III endometrial cancer: patterns of care and impact on overall survival. Gynecol. Oncol.141(3), 421–427 (2016).
   PubMed Web of Science ®Google Scholar
• Hogberg T , SignorelliM, de OliveiraCFet al. Sequential adjuvant chemotherapy and radiotherapy in endometrial cancer – results from two randomised studies. Eur. J. Cancer46(13), 2422–2431 (2010).
   PubMed Web of Science ®Google Scholar
• Yasunaga M , YamasakiF, TokunagaO, IwasakaT. Endometrial carcinomas with lymph node involvement: novel histopathologic factors for predicting prognosis. Int. J. Gynecol. Pathol.22(4), 341–346 (2003).
   PubMed Web of Science ®Google Scholar
• Chen JL , HuangYS, HuangCYet al. Impact of adjuvant radiotherapy on the survival of women with optimally resected stage III endometrial cancer in the era of modern radiotherapy: a retrospective study. Radiat. Oncol.15(1), 72 (2020).
   PubMed Web of Science ®Google Scholar
• Gultekin M , GulerOC, YuceSari Set al. Multi-institutional validation of the ESMO-ESGO-ESTRO consensus conference risk grouping in Turkish endometrial cancer patients treated with comprehensive surgical staging. J. Obstet. Gynaecol.1–7 (2020). doi: 10.1080/01443615.2020.1737661 ( Epub ahead of print).
   Google Scholar
• Casarin J , BoganiG, PiovanoEet al. Survival implication of lymphadenectomy in patients surgically treated for apparent early-stage uterine serous carcinoma. J. Gynecol. Oncol.31(5), e64 (2020).
   PubMed Web of Science ®Google Scholar
• Cignini P , VitaleSG, LaganàAS, BiondiA, LaRosa VL, CutilloG. Preoperative work-up for definition of lymph node risk involvement in early stage endometrial cancer: 5-year follow-up. Updates Surg.69(1), 75–82 (2017).
   PubMed Web of Science ®Google Scholar
• Benati M , MontagnanaM, DaneseEet al. Aberrant telomere length in circulating cell-free DNA as possible blood biomarker with high diagnostic performance in endometrial cancer. Pathol. Oncol. Res.26(4), 2281–2289 (2020).
   PubMed Web of Science ®Google Scholar
• Casarin J , BoganiG, SeratiMet al. Presence of glandular cells at the preoperative cervical cytology and local recurrence in endometrial cancer. Int. J. Gynecol. Pathol.39(6), 522–528 (2020).
   PubMed Web of Science ®Google Scholar
• Mariani A , WebbMJ, KeeneyGL, HaddockMG, CaloriG, PodratzKC. Low-risk corpus cancer: is lymphadenectomy or radiotherapy necessary?Am. J. Obstet. Gynecol.182(6), 1506–1519 (2000).
   PubMed Web of Science ®Google Scholar